文献速递临床试验与 GCP流行病学与生物统计

临床药学模型对用药错误发生率的影响及关联因素:阶梯整群随机对照试验研究方案

Effect and associated factors of a clinical pharmacy model in the incidence of medication errors (EACPharModel) in the Hospital Pablo Tobón Uribe: study protocol for a stepped wedge randomized controlled trial (NCT03338725).
PubMed 文献 · Trials · 2020-01-06

本研究为前瞻性阶梯整群随机对照试验,在哥伦比亚Pablo Tobón Uribe医院5个病房720例患者中比较临床药学实践模型(CPPM)与常规 care 对用药错误发生率的影响。主要结局为用药错误发生率,次要结局为药物相关问题及促成因素,采用混合模型分析,P值<0.05为有统计学意义。

要点

  • 该方案旨在评估CPPM对住院患者用药错误发生率的影响。
  • 采用阶梯整群随机设计,5个病房720例患者,干预随机分配。
  • 主要结局为用药错误发生率,次要结局包括药物相关问题及促成因素。

核心结论

  • 该研究可能为标准化、以患者为中心的临床药学模型改善住院患者安全提供有价值信息。

研究设计与样本

  • 前瞻性、阶梯整群随机对照试验,为期14个月,在哥伦比亚Pablo Tobón Uribe医院5个病房(整群)720例患者中比较CPPM联合常规 care 与常规 care。
  • 整群初始为对照组,2个月观察期后随机分配至干预组,在基线及随机后2、4、6、8、10、12个月评估结局。

关键数值与推荐

  • 主要结局为CPPM对用药使用过程中用药错误发生率的影响。
  • 次要结局为药物相关问题及促成用药错误发生的因素。
  • 统计分析采用混合模型,治疗组和时间作为固定效应,整群结构作为随机效应,P值<0.05为有统计学意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: According to WHO, medication error (ME) is a subject that requires attention at all levels of care to reduce severe and preventable damage related to medication use. Clinical pharmacy practice standards have been proposed around the world so that the pharmacist, as part of a multidisciplinary health team, can help improve patient safety; however, further evidence derived from adequate studies is needed to demonstrate this. This study aims to assess the effect of a clinical pharmacy practice model (CPPM) in preventing MEs associated with the medication use process. METHODS: A prospective, stepped-wedge, cluster-randomized, controlled trial with a duration of 14 months will be performed to compare the effect of a CPPM along with the usual care process of patients in the Pablo Tobón Uribe Hospital (Medellin, Colombia). The study is designed as a cluster-randomized controlled trial, involving five hospital wards (clusters) and 720 patients. Medical wards are allocated to interventions using a stepped-wedge design. Clusters are initially assigned to the control group. After a 2-month observation period, hospital clusters were randomly allocated to the intervention group. Study outcomes will be assessed at baseline and at 2, 4, 6, 8, 10, and 12 months after randomization. The primary outcome will be to assess the effect of a CPPM on the incidence of medication errors associated with the medication use process. Drug-related problems and factors that contribute to the occurrence of MEs will be assessed as secondary outcomes. Statistical analyses will be performed using a mixed model, with the treatment group and time as fixed effects and the clustering structure as a random effect. Statistical analysis will be performed using Pearson chi-square tests and Student's t-tests, and a P value < 0.05 will be considered statistically significant. DISCUSSION: As far as we know, this is the first stepped-wedge, cluster-randomized, controlled trial designed to assess the change of a CPPM on the incidence of medication errors in a hospital in Colombia, and it could generate valuable information about a standardized and patient-centered clinical pharmacy model to improve the safety of inpatient care. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03338725. Registered on 9 November 2017. The first patient was randomized on 2 February 2018. PROTOCOL VERSION: 0010112018JG.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Granados J, Salazar-Ospina A, Botero-Aguirre JP, et al. Effect and associated factors of a clinical pharmacy model in the incidence of medication errors (EACPharModel) in the Hospital Pablo Tobón Uribe: study protocol for a stepped wedge randomized controlled trial (NCT03338725). Trials. 2020. PMID: 31907009. doi:10.1186/s13063-019-3945-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。